Interaction of PRP4 with Krüppel-like factor 13 regulates CCL5 transcription

Journal of Immunology

Volumn 178, Issue 11, 2007, Pages 7081-7087

  Huang, Boli ^a   Ahn, Yong Tae ^a   McPherson, Lisa ^a   Clayberger, Carol ^a   Krensky, Alan M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; KRUPPEL LIKE FACTOR; PROTEIN PRP4; PROTEIN SERINE THREONINE KINASE; RANTES; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BETA CHEMOKINE; CCL5 PROTEIN, HUMAN; CELL CYCLE PROTEIN; KLF13 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PRPF4 PROTEIN, HUMAN; PRPF4B PROTEIN, HUMAN; REPRESSOR PROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ARTICLE; BINDING AFFINITY; CCL5 GENE; CONTROLLED STUDY; DNA LIBRARY; EFFECTOR CELL; ENZYME ASSAY; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; THYMUS; TWO HYBRID SYSTEM; YEAST; ACTIVE TRANSPORT; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL STRAIN COS1; CERCOPITHECUS; CYTOLOGY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING; T LYMPHOCYTE SUBPOPULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE PROTEINS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHEMOKINES, CC; COS CELLS; GENE EXPRESSION REGULATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RANTES; REPRESSOR PROTEINS; RIBONUCLEOPROTEIN, U4-U6 SMALL NUCLEAR; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 34249826626     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.11.7081     Document Type: Article

References (43)

1. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity. 12: 121-127.
2. Keane, M. P., and R. M. Strieter. 1999. The role of CXC chemokines in the regulation of angiogenesis. Chem. Immunol. 72: 86-101.
3. Campbell, J. J., and E. C. Butcher. 2000. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12: 336-341.
4. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology: XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176.
5. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
6. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18: 593-620.
7. Schall, T. J., K. Bacon, K. J. Toy, and D. V., Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671.
8. Kameyoshi, Y., A. Dorschner, A. I. Mallet, E. Christophers, and J. M. Schroder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176: 587-592.
9. Rot, A., M. Krieger, T. Brunner, S. C. Bischoff, T. J. Schall, and C. A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176: 1489-1495.
10. Dahinden, C. A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp. Med. 179: 751-756.
11. Taub, D. D., T. J. Sayers, C. R. Carter, and J. R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155: 3877-3888.
12. Kuna, P., S. R. Reddigari, T. J. Schall, D. Rucinski, M. Y. Viksman, and A. P. Kaplan. 1992. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J. Immunol. 149: 636-642.
13. Alam, R., S. Stafford, P. Forsythe, R. Harrison, D. Faubion, M. A. Lett-Brown, and J. A. Grant. 1993. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 150: 3442-3448.
14. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727-1730.
15. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
16. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666.
17. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85: 1135-1148.
18. Dorunz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85: 1149-1158.
19. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667-673.
20. Nelson, P. J., H. T. Kim, W. C. Manning, T. J. Goralski, and A. M. Krensky. 1993. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J. Immunol. 151: 2601-2612.
21. Nelson, E. L., X. Li, F. J. Hsu, L. W. Kwak, R. Levy, C. Clayberger, and A. M. Krensky. 1996. Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood 88: 580-589.
22. Nelson, P. J., and A. M. Krensky. 1998. Chemokines, lymphocytes and viruses: what goes around, comes around. Curr. Opin. Immunol. 10: 265-270.
23. De Bleecker, J. L., B. De Paepe, I. E. Vanwalleghem, and J. M. Schroder. 2002. Differential expression of chemokines in inflammatory myopathies. Neurology 58: 1779-1785.
24. Ortiz, B. D., A. M. Krensky, and P. J. Nelson. 1996. Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol. Cell. Biol. 16: 202-210.
25. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1997. Nuclear factor-κB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158: 3483-3491.
26. Schall, T. J., J. Jongstra, B. J. Dyer, J. Jorgensen, C. Clayberger, M. M. Davis, and A. M. Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141: 1018-1025.
27. Song, A., Y. F. Chen, K. Thamatrakoln, T. A. Storm, and A. M. Krensky. 1999. RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity 10: 93-103.
28. Ahn, Y. T., B. Huang, L. McPherson, C. Clayberger, and A. M. Krensky. 2007. Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes. Mol. Cell. Biol. 27: 253-266.
29. Nikolcheva, T., S. Pyronnet, S. Y. Chou, N. Sonenberg, A. Song, C. Clayberger, and A. M. Krensky. 2002. A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J. Clin. Invest. 110: 119-126.
30. Huang, B., P. Wu, M. M. Bowker-Kinley, and R. A. Harris. 2002. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator- activated receptor-α ligands, glucocorticoids, and insulin. Diabetes 51: 276-283.
31. Kojima, T., T. Zama, K. Wada, H. Onogi, and M. Hagiwara. 2001. Cloning of human PRP4 reveals interaction with Clk1. J. Biol. Chem. 276: 32247-32256.
32. Song, A., A. Patel, K. Thamatrakoln, C. Liu, D. Feng, C. Clayberger, and A. M. Krensky. 2002. Functional domains and DNA-binding sequences of RFLAT-1/KLF13, a Krüppel-like transcription factor of activated T lymphocytes. J. Biol. Chem. 277: 30055-30065.
33. + gene involved in pre-mRNA splicing codes for a predicted serine/threonine kinase and is essential for growth. Nucleic Acids Res. 21: 4079-4083.
34. Gross, T., M. Lutzelberger, H. Weigmann, A. Klingenhoff, S. Shenoy, and N. F. Kaufer. 1997. Functional analysis of the fission yeast prp4 protein kinase involved in pre-mRNA splicing and isolation of a putative mammalian homologue. Nucleic Acids Res. 25: 1028-1035.
35. Miyata, Y., and E. Nishida. 1999. Distantly related cousins of MAP kinase: biochemical properties and possible physiological functions. Biochem. Biophys. Res. Commun. 266: 291-295.
36. Huang, Y., T. Deng, and B. W. Winston. 2000. Characterization of hPRP4 kinase activation: potential role in signaling. Biochem. Biophys. Res. Commun. 271: 456-463.
37. Dellaire, G., E. M. Makarov, J. J. Cowger, D. Longman, H. G. Sutherland, R. Luhrmann, J. Torchia, and W. A. Bickmore. 2002. Mammalian PRP4 kinase copurifies and interacts with components of both the U5 snRNP and the N-CoR deacetylase complexes. Mol. Cell. Biol. 22: 5141-5156.
38. Bennett, E. M., A. M. Lever, and J. F. Allen. 2004. Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2. J. Virol. 78: 11303-11312.
39. Goehler, H., M. Lalowski, U. Stelzl, S. Waelter, M. Stroedicke, U. Worm, A. Droege, K. S. Lindenberg, M. Knoblich, C. Haenig, et al. 2004. A protein interaction network links GIT1, an enhancer of Huntington aggregation, to Huntington's disease. Mol. Cell 15: 853-865.
40. Song, C. Z., K. Keller, Y. Chen, and G. Stamatoyannopoulos. 2003. Functional interplay between CBP and PCAF in acetylation and regulation of transcription factor KLF13 activity. J. Mol. Biol. 329: 207-215.
41. Foulds, C. E., M. L. Nelson, A. G. Blaszczak, and B. J. Graves. 2004. Ras/ mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/ p300 recruitment. Mol. Cell. Biol. 24: 10954-10964.
42. Muchardt, C., J. C. Reyes, B. Bourachot, E. Leguoy, and M. Yaniv. 1996. The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J. 15: 3394-3402.
43. Barker, N., A. Hurlstone, H. Musisi, A. Miles, M. Bienz, and H. Clevers. 2001. The chromatin remodelling factor Brg-1 interacts with β-catenin to promote target gene activation. EMBO J. 20: 4935-4943.